Navigation Links
High-Risk Heterosexuals Should Take HIV Prevention Pill, Too
Date:8/9/2012

THURSDAY, Aug. 9 (HealthDay News) -- Doctors should consider prescribing the HIV prevention pill Truvada to their heterosexual patients who are at high risk for the virus, not just high-risk gay and bisexual men, experts from the U.S. Centers for Disease Control and Prevention said on Thursday.

The CDC announcement comes on the heels of recent research that revealed that 27 percent of new HIV cases in the United States in 2009 involved heterosexuals who were not injection-drug users. Based on these findings, government health officials advised that the once-a-day pill can also help prevent HIV infection in high-risk heterosexual men and women.

Last month, the U.S. Food and Drug Administration approved the use of Truvada for the reduction of risk for sexual acquisition of HIV infection among adults, including both heterosexuals and gay or bisexual men.

The newly updated CDC guidelines are an attempt to prevent the spread of HIV through heterosexual sex. U.S. health officials noted that Truvada, when taken regularly in combination with other preventative measures, can offer an additional layer of protection for heterosexual men and women at high risk for infection with the virus that causes AIDS.

The CDC is not recommending Truvada for all heterosexuals who are sexually active, and they stress that the condom remains a good first line of defense against HIV. However, couples in which one member is HIV-positive and the other is uninfected may look to Truvada as an option in addition to condom use. And if such a couple wanted to have a baby, Truvada might be a good option in that case as well, Dr. Dawn Smith, the CDC physician who was lead author of the new guidance, told the Associated Press.

CDC officials advised, however, that doctors who consider prescribing the anti-HIV drug for their high-risk heterosexual patients should be certain these men and women are not already infected with the virus. Doctors should also continuously monitor their patients' HIV status and provide this high-risk group with regular counseling on other ways to prevent the spread of HIV, such as practicing safe sex.

High-risk heterosexuals are "not a portion of the epidemic we want to ignore," Smith, of the CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, told AP.

When used as a preventive, the daily pill costs between $6,000 and $12,000 a year, although some private insurers and Medicaid programs may cover it, Smith added.

Although Truvada, made by Gilead Sciences, has been approved since 2004, the CDC authors noted that guidelines on the use of the drug will be updated as more information on its efficacy and safety for all groups at risk for HIV becomes available from additional studies.

In the United States, an estimated 48,100 new HIV infections occurred in 2009, the authors noted in background information in the report, which was published in the Aug. 10 issue of the CDC's Morbidity and Mortality Weekly Report.

More information

Find out more about HIV/AIDS at AIDS.gov.

-- Mary Elizabeth Dallas

SOURCE: U.S. Centers for Disease Control and Prevention, news release, Aug. 9, 2012; Associated Press, Aug. 9, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Lax gun ownership laws could impact ability of high-risk individuals to purchase firearms
2. A better way to help high-risk pregnant smokers
3. Multi-center clinical study intensifies first strike at high-risk cancer in kids
4. New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA
5. Many Breast Cancer Patients in Their 40s Arent High-Risk: Study
6. HIV Prevention Pill Cost-Effective for High-Risk Men: Study
7. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
8. Should young men be vaccinated against human papilloma virus?
9. Disorders of consciousness: How should clinicians respond to new therapeutic interventions?
10. Shots Should Be on College Kids Back-to-School List
11. All HIV Patients Should Take Meds Early On, Experts Now Say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 High-Risk Heterosexuals Should Take HIV Prevention Pill, Too
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of ... announced today its plans to open a flagship location in Covington, LA at 401 ... Rooms To Go store next to Office Depot in the Holiday Square shopping center. ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
Breaking Medicine Technology: